byiShook Opinion
Apr 14, 2025 - 21:50
Bristol Myers Squibb stock skidded late Monday, tugging Cytokinetics lower, after Bristol's drug, Camzyos, failed in a heart disease study. The post Bristol Myers Slumps On Heart Drug Failure — Taking Cytokinetics With It appeared first on Investor's Business Daily.
Bristol Myers Squibb stock skidded late Monday, tugging Cytokinetics lower, after Bristol's drug, Camzyos, failed in a heart disease study.
The post Bristol Myers Slumps On Heart Drug Failure â Taking Cytokinetics With It appeared first on Investor's Business Daily.